Browse 24807 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
January 23rd, 2019 |
Data Coordinating Center for the Diabetic Foot Consortium (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
December 13th, 2019 |
Global Noncommunicable Diseases and Injury Across the Lifespan: Exploratory Research (R21 Clinical Trials Optional) |
National Institutes of Health |
March 4th, 2019 |
Advancing Infectious Disease Detection and Response in Liberia |
Centers for Disease Control and Prevention ERA |
April 30th, 2019 |
Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients |
Centers for Disease Control NCCDPHP |
April 15th, 2019 |
The CDC Cancer Genomics Program: Translating Research into Public Health Practice |
Centers for Disease Control NCCDPHP |
May 10th, 2019 |
2019 Epidemiology and Laboratory Capacity for Prevention and Control of Emerging Infectious Diseases (ELC) |
Centers for Disease Control NCEZID |
January 7th, 2022 |
Strategies to Provide Culturally Tailored Palliative and End-of-Life Care for Seriously Ill American Indian and Alaska Native Individuals (R01 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2022 |
Strategies to Provide Culturally Tailored Palliative and End-of-Life Care for Seriously Ill American Indian and Alaska Native Individuals (R21 Clinical Trial Optional) |
National Institutes of Health |
February 11th, 2019 |
Improving Detection and Management of Glaucoma and Other Eye Diseases Among High Risk Populations |
Centers for Disease Control and Prevention ERA |
January 11th, 2019 |
Prevention and Control of Chronic Disease and Associated Risk Factors in the U.S. Affiliated Pacific Islands, U.S. Virgin Islands, and Puerto Rico |
Centers for Disease Control NCCDPHP |
January 4th, 2019 |
Grants to Expand Substance Abuse Treatment Capacity in Adult Treatment Drug Courts and Adult Tribal Healing to Wellness Courts |
Substance Abuse and Mental Health Services Adminis |
January 7th, 2022 |
NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed) |
National Institutes of Health |
January 7th, 2022 |
Research Project Grant (Parent R01 Clinical Trial Not Allowed) |
National Institutes of Health |
January 16th, 2019 |
Collaborative Study on the Genetics of Alcoholism (COGA) (Clinical Trial Not Allowed U10) |
National Institutes of Health |
January 4th, 2019 |
Grants to Expand Substance Abuse Treatment Capacity in Family Treatment Drug Courts |
Substance Abuse and Mental Health Services Adminis |
January 4th, 2019 |
Statewide Family Network |
Substance Abuse and Mental Health Services Adminis |
January 7th, 2022 |
Research Project Grant (Parent R01 Clinical Trial Required) |
National Institutes of Health |
January 4th, 2019 |
Tribal Behavioral Health Grant Program |
Substance Abuse and Mental Health Services Adminis |
January 7th, 2022 |
NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required) |
National Institutes of Health |
January 7th, 2022 |
NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) |
National Institutes of Health |
|
March 6th, 2019 |
Optimization of Non-addictive Therapies [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Not Allowed) |
National Institutes of Health |
November 4th, 2020 |
Emerging Global Leader Award (K43 Independent Clinical Trial Required) |
National Institutes of Health |
April 25th, 2019 |
Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed) |
National Institutes of Health |
September 7th, 2021 |
Engaging Men in HIV Testing, Prevention, and Care (R01 Clinical Trial Optional) |
National Institutes of Health |
September 7th, 2021 |
Engaging Men in HIV Testing, Prevention, and Care (R21 Clinical Trial Optional) |
National Institutes of Health |
February 15th, 2019 |
National Limb Loss Resource Center |
Administration for Community Living |
November 15th, 2018 |
Sustainable Access for Expanded Voluntary Medical Male circumcision (VMMC) Services (SAFE) |
Tanzania USAID Dar es Salaam |
January 7th, 2022 |
New Research Directions that Advance the NHLBI Strategic Vision Normal Biology (R21 - Clinical Trial Not Allowed) |
National Institutes of Health |
October 18th, 2019 |
NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed) |
National Institutes of Health |
February 11th, 2019 |
Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS)(UG3/UH3 Clinical Trial Required) |
National Institutes of Health |
February 26th, 2019 |
Human Islet Research Network - Consortium on Targeting and Regeneration (HIRN-CTAR) (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
February 11th, 2019 |
Immuno-Oncology Translation Network (IOTN): Immuno-engineering to Improve Immunotherapy (i3) Centers (U54 Clinical Trial Not Allowed) |
National Institutes of Health |
January 14th, 2019 |
Primary Care Training and Enhancement - Physician Assistant Program |
Health Resources and Services Administration |
January 7th, 2022 |
Advancing Research in Augmentative and Alternative Communication (AAC) (R01 Clinical Trial Optional) |
National Institutes of Health |
February 8th, 2019 |
Immuno-Oncology Translation Network (IOTN): Cancer Immunotherapy Research Projects (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
February 8th, 2019 |
Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
February 11th, 2019 |
Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (UG3/UH3) |
National Institutes of Health |
September 5th, 2021 |
Novel Approaches for Relating Genetic Variation to Function and Disease (R43/R44 Clinical Trial Not Allowed) |
National Institutes of Health |
January 7th, 2022 |
Advancing Research in Augmentative and Alternative Communication (AAC) (R21 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2022 |
End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms (R21- Clinical Trial Optional) |
National Institutes of Health |